Ilyang Pharmaceutical

007570 · KOSPI · Health Care · SMALL CAP

[Amended] Disclosure

([Amended] Disclosure)· FILED 2026-10-08· RCEPT 20261008800172

About this filing

The exchange has applied a designation to the company or its shares (for example, an administrative issue, an investor caution or a disclosure-violation penalty).

Why companies file it: Designations warn investors about specific risks or rule breaches.

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-10-08, [Amended] Disclosure
SourceDART rcept 20261008800172 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-10-08 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).